ENTECAVIR VIATRIS 0.5 mg, film-coated tablet 30 tablets, CIP 3400930115572
Active ingredients: Entecavir, Entecavir hydrate
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet30 tablets, CIP 3400930115572orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ENTECAVIR VIATRIS 0,5 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- 30 plaquette(s) thermoformée(s) OPA : polyamide orienté aluminium PVC-Aluminium de 1 comprimé(s)
- Marketing authorisation holder
- VIATRIS (IRLANDE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 20 Dec 2017
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a specialist
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60313672CIP73011557CIP133400930115572Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ENTÉCAVIR MONOHYDRATÉcomprimé | — | SA |
| ENTÉCAVIRcomprimé | 0,50 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.